Abecassis Michael M has filed 5 insider transactions across 1 company since April 2024.
Most recent transaction: a grant/award of 119170 shares of PharmaCyte Biotech, Inc. ($PMCB) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | PharmaCyte Biotech, Inc. | $PMCB | Abecassis Michael M | Director | A | Stock Option (Right to Buy) | 119170 | $0.00 | 119,170.0000 | 10,134,160 | 9999.99% | 1.18% |
| Dec. 12, 2025 | PharmaCyte Biotech, Inc. | $PMCB | Abecassis Michael M | Director | A | Common Stock | 37500 | $0.00 | 39,967.0000 | 6,795,779 | 1520.07% | 0.55% |
| Dec. 12, 2025 | PharmaCyte Biotech, Inc. | $PMCB | Abecassis Michael M | Director | F | Common Stock | 16875 | $1.02 | 23,092.0000 | 6,795,779 | 42.22% | 0.25% |
| April 25, 2025 | PharmaCyte Biotech, Inc. | $PMCB | Abecassis Michael M | Director | A | Stock Option (Right to Buy) | 63233 | $0.00 | 63,233.0000 | 0 | 9999.99% | 0.00% |
| April 30, 2024 | PharmaCyte Biotech, Inc. | $PMCB | Abecassis Michael M | Director | A | Stock Option (Right to Buy) | 38009 | $0.00 | 38,009.0000 | 0 | 9999.99% | 0.00% |